Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04855942
Other study ID # (811)109A-50
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date August 31, 2022

Study information

Verified date July 2022
Source Cheng-Hsin General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trigger finger is the common name of stenosing tenosynovitis of fingers, caused by repetitive trauma. Conservative treatment includes NSAIDs or other analgesic agents, activity modification, splint, and physiotherapy. Operation could be considered if conservative treatments fails. With literature reviewed, there is no treatment which is both non-invasive and effective, and also could avoid recurrence well. Extracorporeal shock wave therapy could induce angiogenesis, anti-inflammatory reaction, and recruitment of fibroblast. Although extracorporeal shock wave has been utilized in musculoskeletal diseases for more than twenty years, there is no well-designed clinical trial to prove the effectiveness of extracorporeal shock wave in treating trigger finger. The purpose of this study is to compare the effectiveness of extracorporeal shock wave therapy with traditional physical therapy for the management of trigger finger.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date August 31, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Quinnel classification grade 2 or 3 - who has only one trigger Exclusion Criteria: - who had ever treated the trigger finger - who has other musculoskeletal disease of the upper limb - who has severe coagulopathy disease - who is pregnant - who has arrhythmia or has a pacemaker - there is sensory impairment, scar, edema at the trigger finger - who has cognitive dysfunction

Study Design


Intervention

Device:
Focused Extracorporeal Shock Wave Therapy (ESWT)
2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks
physiotherapy
therapeutic ultrasound, 12 times in 3 weeks

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cheng-Hsin General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Quinnell stages of triggering Quinnell stages of triggering classifies the trigger finger using five types during flexion and extension: normal movement (Type 0), uneven movement (Type I), actively correctable (Type II), passively correctable (Type III) and fixed deformity (Type IV). 15 weeks
Primary 11-point numeric scale of pain The 11-point numeric scale of pain requires the patient to rate their pain on a defined scale. 0 is no pain and 10 is the worst pain imaginable. 15 weeks
Primary Chinese quick DASH (disabilities of the Arm, Shoulder, and Hand questionnaire) This questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The investigators chose the first two components: the disability and symptom section (11 items, scored 1-5). The lower score means better condition of upper limbs, and vice versa. 15 weeks
Primary strength of hand grip The strength of hand grip is to measure the maximum isometric strength of the hand and forearm muscles by a electicial grip strength device. 15 weeks
Primary sonographic image The investigators would record the characteristics of acquired sonographic images, such like the thickness of finger flexor tendon and A1 pulley, the presence of tendon sheath effusion, and the presence of increased vascularity by Doppler images. 15 weeks
See also
  Status Clinical Trial Phase
Completed NCT04094389 - Comparison of Trigger Finger Orthotic Wearing Schedules N/A
Completed NCT05435950 - Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments N/A
Completed NCT04900220 - Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections Phase 4
Completed NCT04354415 - Tourniquet vs. No Tourniquet for Carpal Tunnel and Trigger Finger Release N/A
Recruiting NCT06296017 - Investigation of the Effectiveness of Different Physiotherapy Applications in Trigger Finger Treatment N/A
Completed NCT06288685 - Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone Phase 3
Active, not recruiting NCT04568993 - The TriggerHappy Trial N/A
Completed NCT04023695 - Trigger Finger Corticosteroid Injection With and Without Local Anesthetic Phase 4
Recruiting NCT04645303 - Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger Early Phase 1
Recruiting NCT03156829 - Effectiveness of Cortisone Injection and Splinting for Trigger Finger Phase 4
Completed NCT01987115 - Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers N/A
Completed NCT02196233 - Surgical Treatment of Adult Trigger Finger
Completed NCT01950793 - A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger N/A
Recruiting NCT04675892 - Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers N/A
Terminated NCT05082480 - Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery N/A
Recruiting NCT05045157 - Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders N/A
Active, not recruiting NCT01886157 - Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting N/A
Recruiting NCT00951236 - Study Comparing One Versus Two Cortisone Injections for Trigger Finger N/A
Completed NCT03886155 - Cardiac Amyloidosis Screening at Trigger Finger Release
Active, not recruiting NCT02084706 - Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection N/A